Table 9.
Results of growth curve analyses of treatment maintenance for full sample of participants who began treatment, with data from individuals who changed medications during treatment or follow up dropped for time points subsequent to the change (N = 26)
| B | t | pr | p | d | |
|---|---|---|---|---|---|
| Primary Outcomes | |||||
| GAD CSR | 0.12 | 0.88 | 0.14 | .382 | 0.25 |
| PSWQ | -1.27 | -1.17 | 7.39 | .249 | 0.35 |
| DASS-Anxiety | 0.03 | 0.06 | 0.88 | .953 | 0.02 |
| DASS-Stress | 1.91 | 2.60 | 0.41 | .013 | 0.89 |
| Secondary Outcomes | |||||
| BDI | 1.22 | 1.65 | 0.50 | .106 | 0.49 |
| QOLI | -0.12 | -0.65 | 0.24 | .520 | 0.11 |
| # of add. diagnoses | 0.01 | 0.10 | 0.37 | .920 | 0.03 |
| Mechanism of Change | |||||
| AAQ | 0.45 | 0.28 | 0.89 | .709 | 0.11 |
| MAAS | 1.13 | 0.81 | 0.84 | .424 | 0.25 |
Note. GAD= generalized anxiety disorder, CSR = Clinician’s Severity Rating from the Anxiety Disorders Interview Schedule for DSM-IV, Lifetime Version; PSWQ = Penn State Worry Questionnaire; DASS-Anxiety = Depression and Anxiety Stress Scales- Anxiety subscale; DASS-Stress = Depression and Anxiety Stress Scales- Stress subscale; BDI = Beck Depression Inventory; QOLI = Quality of Life Inventory; AAQ = Acceptance and Action Questionnaire; MAAS = Mindful Attention and Awareness Scale.